skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
1-L Transcription of SARS-CoV-2 Spike Protein S1 Subunit
Material Type:
Article
Add to My Research

1-L Transcription of SARS-CoV-2 Spike Protein S1 Subunit

International journal of molecular sciences, 2024-04, Vol.25 (8), p.4440 [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;2024 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms25084440 ;PMID: 38674024

Full text available

2
12-month SARS-CoV-2 antibody persistency in a Tyrolean COVID-19 cohort
Material Type:
Article
Add to My Research

12-month SARS-CoV-2 antibody persistency in a Tyrolean COVID-19 cohort

Wiener Klinische Wochenschrift, 2021-12, Vol.133 (23-24), p.1265-1271 [Peer Reviewed Journal]

The Author(s) 2021 ;ISSN: 0043-5325 ;EISSN: 1613-7671 ;DOI: 10.1007/s00508-021-01985-x

Digital Resources/Online E-Resources

3
2-D graphical representation of protein sequences and its application to coronavirus phylogeny
Material Type:
Article
Add to My Research

2-D graphical representation of protein sequences and its application to coronavirus phylogeny

BMB reports, 2008-03, Vol.41 (3), p.217-222 [Peer Reviewed Journal]

ISSN: 1976-6696 ;DOI: 10.5483/bmbrep.2008.41.3.217 ;PMID: 18377725

Full text available

4
35B5 antibody potently neutralizes SARS-CoV-2 Omicron by disrupting the N-glycan switch via a conserved spike epitope
Material Type:
Article
Add to My Research

35B5 antibody potently neutralizes SARS-CoV-2 Omicron by disrupting the N-glycan switch via a conserved spike epitope

Cell host & microbe, 2022-06, Vol.30 (6), p.887-895.e4 [Peer Reviewed Journal]

2022 Elsevier Inc. ;Copyright © 2022 Elsevier Inc. All rights reserved. ;2022 Elsevier Inc. 2022 Elsevier Inc. ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2022.03.035 ;PMID: 35436443

Full text available

5
4,4'-Diaminodiphenyl Sulfone (DDS) as an Inflammasome Competitor
Material Type:
Article
Add to My Research

4,4'-Diaminodiphenyl Sulfone (DDS) as an Inflammasome Competitor

International journal of molecular sciences, 2020-08, Vol.21 (17), p.5953 [Peer Reviewed Journal]

2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms21175953 ;PMID: 32824985

Full text available

6
6-month SARS-CoV-2 antibody persistency in a Tyrolian COVID-19 cohort
Material Type:
Article
Add to My Research

6-month SARS-CoV-2 antibody persistency in a Tyrolian COVID-19 cohort

Wiener Klinische Wochenschrift, 2021-04, Vol.133 (7-8), p.351-358 [Peer Reviewed Journal]

The Author(s) 2020 ;ISSN: 0043-5325 ;EISSN: 1613-7671 ;DOI: 10.1007/s00508-020-01795-7

Digital Resources/Online E-Resources

7
A 10-Minute "Mix and Read" Antibody Assay for SARS-CoV-2
Material Type:
Article
Add to My Research

A 10-Minute "Mix and Read" Antibody Assay for SARS-CoV-2

Viruses, 2021-01, Vol.13 (2), p.143 [Peer Reviewed Journal]

2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 1999-4915 ;EISSN: 1999-4915 ;DOI: 10.3390/v13020143 ;PMID: 33498157

Full text available

8
A 12-Amino Acid Stretch in the Hypervariable Region of the Spike Protein S1 Subunit Is Critical for Cell Fusion Activity of Mouse Hepatitis Virus
Material Type:
Article
Add to My Research

A 12-Amino Acid Stretch in the Hypervariable Region of the Spike Protein S1 Subunit Is Critical for Cell Fusion Activity of Mouse Hepatitis Virus

The Journal of biological chemistry, 1999-09, Vol.274 (37), p.26085-26090 [Peer Reviewed Journal]

1999 © 1999 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology. ;ISSN: 0021-9258 ;EISSN: 1083-351X ;DOI: 10.1074/jbc.274.37.26085 ;PMID: 10473557

Full text available

9
A 193-Amino Acid Fragment of the SARS Coronavirus S Protein Efficiently Binds Angiotensin-converting Enzyme 2
Material Type:
Article
Add to My Research

A 193-Amino Acid Fragment of the SARS Coronavirus S Protein Efficiently Binds Angiotensin-converting Enzyme 2

The Journal of biological chemistry, 2004-01, Vol.279 (5), p.3197-3201 [Peer Reviewed Journal]

2004 © 2004 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology. 2004 ;ISSN: 0021-9258 ;EISSN: 1083-351X ;DOI: 10.1074/jbc.C300520200 ;PMID: 14670965

Full text available

10
A 219-mer CHO-Expressing Receptor-Binding Domain of SARS-CoV S Protein Induces Potent Immune Responses and Protective Immunity
Material Type:
Article
Add to My Research

A 219-mer CHO-Expressing Receptor-Binding Domain of SARS-CoV S Protein Induces Potent Immune Responses and Protective Immunity

Viral immunology, 2010-04, Vol.23 (2), p.211-219 [Peer Reviewed Journal]

2010, Mary Ann Liebert, Inc. ;COPYRIGHT 2010 Mary Ann Liebert, Inc. ;(©) Copyright 2010, Mary Ann Liebert, Inc. ;Copyright 2010, Mary Ann Liebert, Inc. ;ISSN: 0882-8245 ;EISSN: 1557-8976 ;DOI: 10.1089/vim.2009.0090 ;PMID: 20374001

Full text available

11
A 3D structural SARS-CoV-2-human interactome to explore genetic and drug perturbations
Material Type:
Article
Add to My Research

A 3D structural SARS-CoV-2-human interactome to explore genetic and drug perturbations

Nature methods, 2021-12, Vol.18 (12), p.1477-1488 [Peer Reviewed Journal]

2021. The Author(s), under exclusive licence to Springer Nature America, Inc. ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2021. ;ISSN: 1548-7091 ;EISSN: 1548-7105 ;DOI: 10.1038/s41592-021-01318-w ;PMID: 34845387

Full text available

12
Ab-CoV: a curated database for binding affinity and neutralization profiles of coronavirus-related antibodies
Material Type:
Article
Add to My Research

Ab-CoV: a curated database for binding affinity and neutralization profiles of coronavirus-related antibodies

Bioinformatics, 2022-08, Vol.38 (16), p.4051-4052 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;The Author(s) 2022. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 1367-4803 ;EISSN: 1460-2059 ;EISSN: 1367-4811 ;DOI: 10.1093/bioinformatics/btac439 ;PMID: 35771624

Full text available

13
Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets
Material Type:
Article
Add to My Research

Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets

Blood, 2021-10, Vol.138 (16), p.1481-1489 [Peer Reviewed Journal]

2021 American Society of Hematology ;2021 by The American Society of Hematology. ;2021 by The American Society of Hematology 2021 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2021011871 ;PMID: 34315173

Full text available

14
Ablation of CD8 + T cell recognition of an immunodominant epitope in SARS-CoV-2 Omicron variants BA.1, BA.2 and BA.3
Material Type:
Article
Add to My Research

Ablation of CD8 + T cell recognition of an immunodominant epitope in SARS-CoV-2 Omicron variants BA.1, BA.2 and BA.3

Nature communications, 2022-10, Vol.13 (1), p.6387-6387, Article 6387 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-022-34180-1 ;PMID: 36302758

Full text available

15
ABO blood group is involved in the quality of the specific immune response anti-SARS-CoV-2
Material Type:
Article
Add to My Research

ABO blood group is involved in the quality of the specific immune response anti-SARS-CoV-2

Virulence, 2022-12, Vol.13 (1), p.30-45 [Peer Reviewed Journal]

2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 ;2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 The Author(s) ;ISSN: 2150-5594 ;EISSN: 2150-5608 ;DOI: 10.1080/21505594.2021.2019959 ;PMID: 34967260

Full text available

16
Absence of SARS-CoV-2 Spike glycoprotein expression in placentas from individuals after mRNA SARS-CoV-2 vaccination
Material Type:
Article
Add to My Research

Absence of SARS-CoV-2 Spike glycoprotein expression in placentas from individuals after mRNA SARS-CoV-2 vaccination

Modern pathology, 2022-09, Vol.35 (9), p.1175-1180 [Peer Reviewed Journal]

2022 United States & Canadian Academy of Pathology ;2022. The Author(s), under exclusive licence to United States & Canadian Academy of Pathology. ;The Author(s), under exclusive licence to United States & Canadian Academy of Pathology 2022. ;The Author(s), under exclusive licence to United States & Canadian Academy of Pathology 2022 ;ISSN: 0893-3952 ;EISSN: 1530-0285 ;DOI: 10.1038/s41379-022-01061-3 ;PMID: 35361888

Full text available

17
Accessible and Adaptable Multiplexed Real-Time PCR Approaches to Identify SARS-CoV-2 Variants of Concern
Material Type:
Article
Add to My Research

Accessible and Adaptable Multiplexed Real-Time PCR Approaches to Identify SARS-CoV-2 Variants of Concern

Microbiology spectrum, 2022-10, Vol.10 (5), p.e0322222-e0322222 [Peer Reviewed Journal]

Copyright © 2022 Yan et al. ;Copyright © 2022 Yan et al. 2022 Yan et al. ;ISSN: 2165-0497 ;EISSN: 2165-0497 ;DOI: 10.1128/spectrum.03222-22 ;PMID: 36106882

Full text available

18
ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial
Material Type:
Article
Add to My Research

ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial

Attribution 4.0 International https://creativecommons.org/licenses/by/4.0 ;DOI: 10.17863/CAM.57823

Digital Resources/Online E-Resources

19
ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial
Material Type:
Article
Add to My Research

ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial

Current controlled trials in cardiovascular medicine, 2020-07, Vol.21 (1), p.691-3, Article 691 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1745-6215 ;EISSN: 1745-6215 ;EISSN: 1468-6694 ;DOI: 10.1186/s13063-020-04584-9 ;PMID: 32736596

Full text available

20
Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays
Material Type:
Article
Add to My Research

Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays

Scientific reports, 2021-03, Vol.11 (1), p.6614-6614, Article 6614 [Peer Reviewed Journal]

The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-021-86035-2 ;PMID: 33758278

Full text available

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (4,926)

Refine My Results

Creation Date 

From To
  1. Before 1995  (32)
  2. 1995 To 2001  (84)
  3. 2002 To 2008  (285)
  4. 2009 To 2016  (287)
  5. After 2016  (4,364)
  6. More options open sub menu

Resource Type 

  1. Articles  (5,048)
  2. Web Resources  (1)
  3. Patents  (1)
  4. magazinearticle  (1)
  5. More options open sub menu

Language 

  1. English  (5,043)
  2. Japanese  (917)
  3. Chinese  (8)
  4. Norwegian  (4)
  5. Spanish  (4)
  6. French  (3)
  7. Portuguese  (3)
  8. Russian  (2)
  9. Swedish  (1)
  10. Korean  (1)
  11. Croatian  (1)
  12. More options open sub menu

Searching Remote Databases, Please Wait